Amputation, Neuroma Amputation, Phantom Limb Pain, Residual Limbs
Conditions
Keywords
Targeted Muscle Re-innervation, Regenerative Peripheral Nerve Interface, TMR, RPNI
Brief summary
The purpose of this study is to analyze the efficacy of novel interventions in post-amputation surgical care (specifically Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interface) on post-amputation pain and functional outcomes at the time of amputation. These novel interventions have been shown to be successful in treating the downstream effects of amputations (pain, phantom limb pain, neuroma pain, etc.), but has not been studied in a randomized manner at the time of amputation.
Detailed description
The investigators plan a randomized control trial of all eligible patients undergoing major limb amputation at Parkland Memorial Hospital. Eligible patients undergoing an amputation will be consented for all possible interventions and randomized to either receive Targeted Muscle Re-Innervation (TMR), Regenerative Peripheral Nerve Interface (RPNI), or standard post-amputation surgical care at the time of their operation. Key pre-operative data including patient sex, age, BMI, past medical history, past surgical history, medications, allergies, social history, social support systems, exposure to narcotic medication, and reason for amputation will be analyzed. Intra-operatively, patients randomized to the treatment arm will receive TMR or RPNI and the transected nerve ends addressed will be recorded. Post-operative data that will be recorded include hospital stay, complications related to the procedure, complications leading to reoperation, functional results, need for pain medication, incidence of phantom limb pain, incidence of painful neuromas, length of follow-up, and all adverse events/complications. Analyses will be conducted using data obtained from patient medical records from the Parkland Health & Hospital System.
Interventions
PROCEDURETargeted Muscle Re-innervation
Targeted Muscle Re-innervation involves re-routing transected nerve ends to functional motor nerves proximal to the site of amputation.
Regenerative Peripheral Nerve Interface involves placing transected nerve ends in harvested muscle grafts.
PROCEDUREStandard Post-Amputation Surgical Care
Standard post-amputation surgical care involves placing transected nerve ends into muscle/soft tissue proximal to the site of amputation.
Sponsors
University of Texas Southwestern Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Patients ≥18 years old * Patients scheduled for amputation of upper or lower extremity (including digit, ray, and hand) as a primary or secondary sequela of trauma. * Patients scheduled for amputation of upper or lower extremity (including digit, ray, and hand) for primary or secondary sequelae of malignancy. * Secondary sequalae include but is not limited to metastatic disease and osteolytic disease. * Patients scheduled for amputation of upper or lower extremity (including digit, ray, and hand) for vasculitic diseases.
Exclusion criteria
* Patients less than 18 years old * Patients with cognitive impairment * Patients who are imprisoned at the time of randomization * Patients currently enrolled in other studies relating to neuropathic pain * Patients actively undergoing radiation therapy * Patients with existing neuroma or underwent prior neuroma surgery * Patients with amputations scheduled congenital reasons
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Phantom Limb Pain | Specifically at the time point 1 year after their primary incisions have healed. | The primary outcome measure of the study will the incidence of phantom limb pain in each group over the course of the recovery period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity score as measured PROMIS (Patient Reported Outcomes Measurement Information System) score | Until 2 years after incisions have healed. | Pain intensity score is measured bv PROMIS (Patient Reported Outcomes Measurement Information System) Scores via patient questionnaires administered at follow-up visits. Possible scores range from 1-5 where higher scores indicate worse outcome (pain severity). |
| Pain interference score as measured by PROMIS (Patient Reported Outcomes Measurement information System) questionnaire | Until 2 years after incisions have healed. | Pain interference score as measured by PROMIS (Patient Reported Outcomes Measurement information System) scores via patient questionnaires administered at follow-up visits. Possible scores range from 1-5, where higher scores indicate worse outcome (pain interference). |
| Pain behavior measured by PROMIS (Patient Reported Outcomes Measurement Information System) questionnaire | Until 2 years after incisions have healed. | Pain behavior score measured by PROMIS (Patient Reported Outcomes Measurement Information System) questionnaire that pertains to subject social health. Raw summed score from 8 to 40, where 40 represents severely maladaptive pain behavior. |
| Narcotic medical use post-operatively as measured by MME (Morphine Milligram Equivalent) Score | Until 2 years after incisions have healed. | Narcotic medical use post-operatively as measured by MME (Morphine Milligram Equivalent) Score This is a tool to condense and standardize the patient's narcotic pain regimen. |
Outcome results
None listed